BMCM
TECH icon

Bryn Mawr Capital Management’s Bio-Techne TECH Stock Holding History

Bryn Mawr Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Buy
4,141
+155
+4% +$8.37K 0.01% 376
2026
Q1 		$208K Buy
3,986
+194
+5% +$11.6K 0.01% 420
2025
Q4 		$223K Buy
+3,792
New +$230K 0.01% 417

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bryn Mawr Capital Management's TECH Position: Q2 2026 in Review

Bryn Mawr Capital Management increased its Bio-Techne (TECH) stake by 3.9% in Q2 2026, buying an estimated $8.37K and bringing the position to 4,141 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #376.

Bryn Mawr Capital Management first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Bryn Mawr Capital Management held 4,141 shares of Bio-Techne worth $293K as of Q2 2026.
  • Bryn Mawr Capital Management bought 155 Bio-Techne shares in Q2 2026, an estimated $8.37K.
  • Bio-Techne made up 0.01% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #376 holding.
  • Bryn Mawr Capital Management first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.